Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06112860 · ClinicalTrials.gov registry record · NA
OTC Hearing Aid and MCI
A NA study of Mild Cognitive Impairment and Hearing Loss, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT06112860: Recruiting NA study of Mild Cognitive Impairment and Hearing Loss, sponsored by Northwestern University.
NCT06112860 is a NA study of Mild Cognitive Impairment and Hearing Loss that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 50 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06112860, a NA study of Mild Cognitive Impairment and Hearing Loss, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: 1. improve communication 2. Whether the magnitude of benefit depends on the patient's level of cognitive disability, 3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits. Participants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.
Primary Outcome
A questionnaire completed by the communication partner of the individual with MCI and hearing loss. On this scale, higher scores reflect more frequent and more problematic conversation difficulties; item possible scores range from 0 (not problematic) to 7 (.very problematic)
Conditions Studied
Interventions
- DEVICE Over the counter hearing aid
- BEHAVIORAL Communication Strategies Information/Counseling
Study Locations (3)
Wisconsin
- La Crosse Mayo Clinic - La Crosse
- UW Madison - Madison
Illinois
- Northwestern University HA Lab - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06112860 shows while recruiting
NCT06112860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Over the counter hearing aid is the first listed.
NCT06112860 reports a single indexed study location in Wisconsin, Illinois.
Frequently Asked Questions
What is clinical trial NCT06112860 about?
NCT06112860 is a clinical study titled "OTC Hearing Aid and MCI". The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: 1. improve communication 2. Whether the magnitude of ...
What is the current status of trial NCT06112860?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-07-23. Estimated completion is 2026-12-31.
What conditions does trial NCT06112860 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Hearing Loss, Alzheimer Disease and Related Dementias (ADRD).
What interventions are being tested in trial NCT06112860?
The interventions under investigation include: Over the counter hearing aid (DEVICE), Communication Strategies Information/Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06112860?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06112860 being conducted?
This trial has 3 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06112860's enrollment target sits among peer trials
50 140th of 205 higher than 62 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI